BioLeader Interview - PIR International
Well-financed biotech company to enter the clinic in 2020
AU 2016/279486 A1 - Compounds For Use In Treating Neuromuscular Disorders - The Lens - Free & Open Patent and Scholarly Search
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Initiator Pharma
NMD Pharma A/S | LinkedIn
PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO SHAREHOLDERS IN SANIONA AB
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Initiator Pharma
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
NMD Pharma
Annual Report 2016 by Lundbeckfonden - issuu
NMD Pharma
Initiator Pharma
WO2016202341A1 - Compounds for use in treating neuromuscular disorders - Google Patents
NMD Pharma A/S | LinkedIn
Company Presentation
Prominent Canadian researcher in Denmark: Why I left a top job in California
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile
